Medicine and Dentistry
Angiogenesis Inhibitor
100%
Retina Neovascularization
100%
Adeno Associated Virus Vector
100%
Age Related Macular Degeneration
50%
Tissue Inhibitor of Metalloproteinase 3
50%
Choroidal Neovascularization
50%
Retinopathy of Prematurity
50%
Gene Transfer
50%
Eye Disease
50%
Diabetic Retinopathy
50%
Visual Impairment
50%
Ischemia
50%
Endostatin
50%
Keyphrases
Neovascularization
100%
Retinal Neovascularization
100%
Antiangiogenic Agents
100%
Ocular Diseases
50%
Three-vector
50%
Visual Loss
50%
Antiangiogenic Factors
50%
TIMP3
50%
Endostatin
50%
Myopic Choroidal Neovascularization (mCNV)
50%
Age-related Macular Degeneration
50%
Retinopathy of Prematurity
50%
Pharmacology, Toxicology and Pharmaceutical Science
Retina Neovascularization
100%
Angiogenesis Inhibitor
100%
Neovascularization (Pathology)
100%
Pigment Epithelium Derived Factor
50%
Age Related Macular Degeneration
50%
Tissue Inhibitor of Metalloproteinase 3
50%
Retrolental Fibroplasia
50%
Visual Impairment
50%
Angiogenic Factor
50%
Endostatin
50%
Subretinal Neovascularization
50%
Neuroscience
Angiogenesis Inhibitor
100%
Stromelysin
50%
Choroidal Neovascularization
50%
Metalloprotease Inhibitor
50%
Retinopathy of Prematurity
50%
Age-Related Macular Degeneration
50%
Angiogenic Factor
50%
Endostatin
50%
Pigment Epithelium Derived Factor
50%